Pacific BioLabs is a leading CRO specializing in biocompatibility testing for medical devices, offering comprehensive in vitro, in vivo, and analytical services to ensure product safety and regulatory compliance.
Pacific BioLabs is a premier Contract Research Organization (CRO) dedicated to providing comprehensive biocompatibility testing services for medical devices. They specialize in ensuring that devices and materials are compatible with biological systems, adhering to critical international standards such as ISO 10993. Their expertise spans in vitro testing, including cytotoxicity and extractables/leachables analysis (ISO 10993-18), as well as in vivo testing for skin irritation, sensitization, and implantation. Pacific BioLabs also offers hemolysis testing (ASTM F756) and chemical characterization to support regulatory submissions. With a strong emphasis on quality systems, cGMP/GLP compliance, and continuous improvement, Pacific BioLabs guides manufacturers through the complex process of biocompatibility assessment. They help determine the necessary tests, develop biological evaluation plans (BEPs), and ensure compliance with FDA, EU, and other global regulatory requirements, ultimately prioritizing patient safety.
About
**Who they are** Pacific BioLabs is a Contract Research Organization (CRO) specializing in life science testing, including comprehensive biocompatibility testing for medical devices. They focus on ensuring product safety and regulatory compliance.
**Expertise & scope** * Biocompatibility testing services aligned with ISO 10993 standards. * In vitro testing, including cytotoxicity (MEM Elution, Agarose Overlay, Direct Contact). * In vivo biocompatibility testing. * Extractables and leachables testing (chemical characterization) per ISO 10993-18. * Hemolysis testing according to ASTM F756. * Support for medical device, delivery device, and combination product services. * Analytical, bioanalytical, and microbiology testing services. * Pharm/Biopharm manufacturing and drug development support, including ICH stability testing and ICP-MS trace elemental analysis.
**Reputation / proof points** * FDA registered. * ISO 17025 accredited. * Animal science operations accredited by AAALAC.
Additional information
Pacific BioLabs emphasizes a structured approach to biocompatibility testing, beginning with planning. This involves understanding device materials, manufacturing, and sterilization processes. They recommend developing a Biological Evaluation Plan (BEP) to determine necessary tests, often starting with chemical characterization and in vitro screening before proceeding to in vivo studies. Their Biocompatibility Planning Tool (BioPT) can assist manufacturers in this process. The company operates under cGMP/GLP compliance and holds ISO certification, underscoring their commitment to quality systems and regulatory adherence.
Key Highlights
Specializes in biocompatibility testing for medical devices, including in vitro, in vivo, and analytical services.
Source
“Pacific BioLabs is a leading CRO specializing in biocompatibility testing for medical devices, offering comprehensive in vitro, in vivo, and analytical services”
Offers specific in vitro cytotoxicity tests such as MEM Elution, Agarose Overlay, and Direct Contact.
Source
“There are three in vitro cytotoxicity tests that PBL performs: MEM Elution, Agarose Overlay, and Direct Contact.”
Performs extractables and leachables testing, crucial for chemical characterization under ISO 10993-18.
Source
“Device Extractables and Leachables – ISO 10993-18”
Conducts hemolysis testing in accordance with ASTM F756.
Source
“Hemolysis Testing – ASTM F756”
Is FDA registered and ISO 17025 accredited.
Source
“PBL is FDA registered and is ISO 17025 accredited.”